Anti-Clq antibodies in patients with chronic hepatitis C infection

Clinical and Experimental Rheumatology

Volumn 24, Issue 2, 2006, Pages 183-185

  Lienesch, Douglas W ^a,d   Sherman, Kenneth E ^a   Metzger, Allan ^b,c   Shen, GuoQiu ^c  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c RDL Reference Laboratory   (United States)

^d NONE   (United States)

Author keywords

Anti Clq antibody; Autoimmunity; HCV

Indexed keywords

AUTOANTIBODY;

ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; CRYOGLOBULINEMIA; HEPATITIS C; HUMAN; INDIVIDUALITY; MAJOR CLINICAL STUDY; MIXED CONNECTIVE TISSUE DISEASE; OBSERVATIONAL STUDY; PATHOGENESIS; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RHEUMATOID ARTHRITIS; SCLERODERMA; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS;

ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; COMPLEMENT C1Q; CRYOGLOBULINEMIA; HEPATITIS C, CHRONIC; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIXED CONNECTIVE TISSUE DISEASE; SCLERODERMA, SYSTEMIC; SJOGREN'S SYNDROME; VASCULITIS;

EID: 33744820001     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. AGNELLO V, DE ROSA FG: Extrahepatic disease manifestations of HCV infection: some current issues. J Hepatol 2004; 40: 341-52.
2. COREMANS LE, SPRONK PE, BOOTSMA H et al.: Changes in antibodies to Cl q predict renal relapses in systemic lupus erythematosus. Am J Kidney Dis 1995; 26: 595-601.
3. OELZNER P. DELIYSKA B, FUNFSTUCK R, HEM G, HEMNANN D, STEIN G: Anti-Clq antibodies and antiendothelial cell antibodies in systemic lupus erythematosus relationship with disease activity and renal involvement. Chin Rheumatol 2003; 22: 271-8.
4. WISNIESKI JJ, NAFF GB: Serum IgG antibodies to Clq in hypocomplementemic urticarial vasculitis syndrome. Arthritis Rheum 1989; 32: 1119-27.
5. SIEGERT CE, DALIA MR, VAN DER VOORT EA, BREEDVELD FC: IgG and IgA antibodies to the collagen-like region of Cl q in rheumatoid vasculitis. Arthritis Rheum 1990; 33: 1646-54
6. GUNNARSSON I, RONNELID J, LUNDBERG I, JACOBSON SH: Occurrence of anti-Clq antibodies in IgA nephropatby. Nephrol Dial Transplant 1997; 12: 2263-8
7. COREMANS LE, DALIA MR. VAN DER VOORT EA, MUIZERT Y, HALMA C, BREEDVELD FC: Antibodies against Cl q in anti-glomerular basement membrane nephritis. Clin Exp Immunol 1992; 87: 256-60.
8. PROHASZKA Z, DALIA MR, SUSAL C et al.: Clq autoantibodies in HIV infection: correlation to elevated levels of autoantibodies against 60-kDa heat-shock proteins. Clin Immunol 1999; 90: 247-55.
9. TROUW LA, GROENEVELD TW, SEELEN MA et al.: Anti-Clq autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular Clq-containing immune complexes. J Clin Invest 2004; 114: 679-88.
10. LIENESCH D, MORRIS R, METZGER A, DEBUYS P, SHERMAN K: Absence of cyclic citrullinated peptide antibody in non-arthritic patients with chronic hepatitis C infection. J Rheumatol 2005; 32: 489-93.
11. SEELEN MA, TROUW LA, DAHA MR: Diagnostic and prognostic significance of antiClq antibodies in systemic lupus erythematosus. Curr Opin Nephrol Hypertens 2003; 12: 619-24.
12. SENE D, GHILLANI-DALBIN P. THIBAULT V et al.: Longterm course of mixed cryoglobulinemia in patients infected with hepatitis C virus. J Rheumatol 2004; 31: 2199-206.